An Oral Fluorouracil Prodrug, Capecitabine, Mitigates a Gram-Positive Systemic Infection in Mice
Journal Article
Overview
publication date
- September 1, 2021
has subject area
- Administration, Oral
- Animals
- Animals, Inbred Strains - Mice, Inbred BALB C
- Anti-Bacterial Agents
- Deoxyribonucleosides - Capecitabine
- Female
- Fluorouracil
- Fluorouracil - Capecitabine
- Gammaproteobacteria - Salmonella typhimurium
- Gram-Negative Facultatively Anaerobic Rods - Salmonella typhimurium
- Humans
- Mice
- Mice - Mice, Inbred BALB C
- Nucleic Acids, Nucleotides, and Nucleosides - Capecitabine
- Prodrugs
- Pyrimidines - Capecitabine
- Staphylococcal Infections
has restriction
- green
Date in CU Experts
- July 4, 2021 6:41 AM
Full Author List
- McLeod JR; Harvey PA; Detweiler CS
author count
- 3
citation count
- 4
published in
- Microbiology Spectrum Journal
Other Profiles
International Standard Serial Number (ISSN)
- 2165-0497
Digital Object Identifier (DOI)
Additional Document Info
volume
- 9
issue
- 1
number
- ARTN e00275-21